BioSpace News Archive

Co-development and implementation of a new CRISPR-based screening technology platform to address critical gaps in target ID and validation

Congenica, the global provider of clinical genomics interpretation software, today announced the appointment of Mrs Wendy Britten as its new Chief Financial Officer (CFO), effective 1st September, 2018.

Insulet Corporation today announced that management will present at two upcoming investor conferences in New York City, New York:

Caris Life Sciences® today announced that the company has been selected by the Hoosier Cancer Research Network and the study’s sponsor investigator, Dr. Matthew Galsky, to perform genomic tumor profiling for a new Phase II bladder cancer clinical trial, HCRN GU16-257.

BD (Becton, Dickinson and Company), Direct Relief, and the National Association of Community Health Centers (NACHC) recently awarded five community health centers with a total of $1 million in grant funding, which will be used to expand programs that help vulnerable patients more effectively manage their medications.

Dr. Frank Torti, former partner at NEA, appointed Vant Investment Chair

Correvio Pharma Corp. is a revenue-generating, specialty pharmaceutical company focused on providing innovative, high-quality brands that meet the needs of acute care physicians and patients.

Conference in New York City on Tuesday, September 4, 2018 at the New York Marriott East Side Hotel

KBI Biopharma BVBA initiated its first client-sponsored programs in May 2018.

Extensive Experience in Medical Device Industry Aligns with Organization’s Next Step in Healthcare Supply Chain